CF vs SYRE · P/E 12, rev $4.21B vs $7.60B cap
CF Industries Holdings Inc (CF) versus Spyre Therapeutics Inc. (SYRE) — a side-by-side from cached financials, not a winner call.
CF Industries Holdings Inc (CF) is a agricultural inputs company listed on US.
Spyre Therapeutics Inc. (SYRE) is a biotechnology company listed on NASDAQ.
Latest reported CF revenue for 2026-06-30 was $4.21B. Net income was $1.54B. CF currently screens at market cap $14.98B and trailing P/E 12.2.
Latest reported SYRE revenue for 2025-12-31 was $0. Net income was -$155.2M. SYRE currently screens at market cap $7.60B.
CF currently screens at market cap $14.98B and trailing P/E 12.2. SYRE currently screens at market cap $7.60B.
Not investment advice. Open the CF and SYRE stock pages for the full models.
Not investment advice.